A new partnership aims to ensure that transformative diagnostic and healthcare technologies reach patients fast.
Darktrace, a leading autonomous cyber security AI company, today announced that it has joined forces with software giant Microsoft. The partnership provides mutual customers with enterprise-scale, self-learning AI that detects and autonomously responds to cyber-threats.
Top 100 law firm, Birketts, has assisted leading software company, Matterlab Ltd, in securing investment from a group of high net worth individuals for an undisclosed sum. The Matterlab team include directors, shareholders and co-founders, Mark Thorley, David Flynn and Radu Gidei.
A ten-point action plan, which includes the creation of a new UK trade committee chaired by the Prime Minister, has been launched as part of a major new report.
University of Cambridge spin-out company HexagonFab today announced a £1.9 million seed funding round, led by Cambridge Enterprise, joined by Parkwalk, New Grounds VC, Silicon Valley-based R42 Group, and several private investors.
Johnson Matthey (JM), a global leader in sustainable technologies, today announces significant strategic developments in the commercialisation of eLNO – its portfolio of leading nickel rich advanced cathode materials – which put JM at the forefront of providing a sustainable and secure supply of cathode materials for customers, in line with its...
Dr Scott Keene, Research Associate in Neurotechnology at the University of Cambridge, has been awarded a major research fellowship by the European Commission.
Inotec AMD is delighted to have secured Wealth Club investment towards its Series C funding.
Local businesses supported by Innovate UK are getting the east and south-east of England ready to build back better after coronavirus.
Illumina, Inc. has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the US and UK. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups, invested in four companies for the second funding cycle of Illumina Accelerator Cambridge...
CybSafe, the behavioural security platform that’s transforming the way organisations manage human cyber risk, has announced a £5.6m ($7.9m) Series A round. It was led by deep tech investors IQ Capital with participation from Hannover Digital Investments GmbH (HDI Group) and B8 Ventures.
Two scaleups from the East of England - Cambridge-based Riverlane and Speechmatics - have been selected in Tech Nation’s latest Upscale Programme.
New funding will accelerate Riverlane’s mission to build a high-performance operating system that makes quantum computers useful, sooner.
Deepesh Thakrar, senior debt finance director at OakNorth Bank, highlights the opportunities in lending to hotels.
R4DAR Technologies, a disruptive tech start-up in the autonomous landscape, has secured £74k in SBRI (Small Business Research Initiative) funding from the Geospatial Transport Innovation Competition to study the feasibility of delivering a cutting-edge locational data solution for widescale use in shared transport networks, smart city and smart...
LPA Lighting Systems has been awarded a signficant contract to design and manufacture an advanced ‘at seat’ electronics system solution for Grammer AG, one of the world’s leading manufacturers of seating systems.
Medovate and its Brisbane-based distributor LTR Medical have announced they have secured both TGA (Therapeutic Goods Administration) Approval in Australia and inclusion on the WAND Database in New Zealand for their game-changing SAFIRA™ (SAFer Injection for Regional Anaesthesia) technology.
Spirea Limited, a spin-out from the University of Cambridge, which was founded to deliver the next generation of antibody drug conjugate (ADC) cancer therapeutics, has today announced that it has secured financing from lead o2h Ventures and Syndicate Room.
Blue Tap, a water purification social enterprise founded by University of Cambridge PhD student Francesca O’Hanlon, has secured an Innovate UK Smart Grant towards the technical development of its chlorine doser for use in developing countries.
Endomag, a breast cancer market leader and one of the UK’s fastest growing private technology businesses1, has secured £15m (~$20m) in Series D funding. These funds are earmarked for expanding access to new advanced techniques enabled by its products, such as targeted axillary dissection (TAD) and delayed sentinel lymph node biopsy (...